PFH, pure fetal histology; EMEF, epithelial mixed embryonal/fetal; MEM, mixed epithelial-mesenchymal; SCU, small cell undifferentiated; C5V: vincristine+5-fluorouracil+cisplatin; PLADO: cisplatin+doxorubicin
Legend
Figure 1. Kaplan–Meier curves for event-free and overall survival; A Event-free survival; B Overall survival
1 Hubbard, A. K., Spector, L. G., Fortuna, G., Marcotte, E. L. & Poynter, J. N. Trends in International Incidence of Pediatric Cancers in Children Under 5 Years of Age: 1988-2012. JNCI Cancer Spectr3 , pkz007 (2019).https://doi.org:10.1093/jncics/pkz007
2 Linabery, A. M. & Ross, J. A. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 112 , 416-432 (2008).https://doi.org:10.1002/cncr.23169
3 Yang, T., Whitlock, R. S. & Vasudevan, S. A. Surgical Management of Hepatoblastoma and Recent Advances. Cancers (Basel) 11(2019).https://doi.org:10.3390/cancers11121944
4 Perilongo, G. et al. Risk-adapted treatment for childhood hepatoblastoma: final report of the second study of the International Society of Paediatric Oncology—SIOPEL 2. European journal of cancer (1990) 40 , 411-421 (2004).https://doi.org:10.1016/j.ejca.2003.06.003
5 Hiyama, E. et al. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol. J Clin Oncol 38 , 2488-2498 (2020).https://doi.org:10.1200/JCO.19.01067
6 Katzenstein, H. M. et al. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children’s Oncology Group, multicentre, phase 3 trial. Lancet Oncol 20 , 719-727 (2019).https://doi.org:10.1016/S1470-2045(18)30895-7
7 Marin, J. J. G. et al. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma. Cancers (Basel) 11 (2019).https://doi.org:10.3390/cancers11030407
8 Ortega, J. A. et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children’s Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18 , 2665-2675 (2000).https://doi.org:10.1200/JCO.2000.18.14.2665
9 Warmann, S. W. & Fuchs, J. Drug resistance in hepatoblastoma.Current pharmaceutical biotechnology 8 , 93-97 (2007).https://doi.org:10.2174/138920107780487456
10 Meyers, R. L. et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration. Lancet Oncol 18 , 122-131 (2017).https://doi.org:10.1016/S1470-2045(16)30598-8
11 Roebuck, D. J. et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 37 , 123-132; quiz 249-150 (2007).https://doi.org:10.1007/s00247-006-0361-5
12 Vasudevan, S. A. et al. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children’s Oncology Group Trial, AHEP0731. J Pediatr Surg 57 , 251-256 (2022).https://doi.org:10.1016/j.jpedsurg.2022.05.022
13 Saxena, R. et al. Chemotherapy effects on hepatoblastoma. A histological study. Am J Surg Pathol 17 , 1266-1271 (1993).https://doi.org:10.1097/00000478-199312000-00008
14 Aronson, D. C. et al. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report. Eur J Cancer 106 , 126-132 (2019).https://doi.org:10.1016/j.ejca.2018.10.013
15 Ren, X. et al. Results of surgical resections with positive margins for children with hepatoblastoma: Case series from a single Asian center. Pediatric blood & cancer 66 , e27479-n/a (2019).https://doi.org:10.1002/pbc.27479
16 Heifetz, S. A., French, M., Correa, M. & Grosfeld, J. L. Hepatoblastoma: The Indiana Experience with Preoperative Chemotherapy for Inoperable Tumors; Clinicopathological Considerations.Pediatric Pathology & Laboratory Medicine 17 , 857-874 (2010).https://doi.org:10.1080/15513819709168750
17 Wang, L. L. et al. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. Am J Surg Pathol 34 , 287-299 (2010).https://doi.org:10.1097/PAS.0b013e3181ce5f1e
18 Ren, X., Li, H., Diao, M., Xu, H. & Li, L. Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study. International Journal of Clinical Oncology 25 , 765-773 (2019).https://doi.org:10.1007/s10147-019-01573-0